Announcement on Voluntary Disclosure of Releasing Relevant Data of APL-1702 International Multicenter Phase III Clinical Trial at IPVC 2024

About this update from Jiangsu Yahong Meditech Co., Ltd. Class A

Announcement on Voluntary Disclosure of Releasing Relevant Data of APL-1702 International Multicenter Phase III Clinical Trial at IPVC 2024 The abstract is for reference only. Please refer to the full text of the announcement on the very day. Link of Full Text for Reference: View Attachment

View stock analysis, news, and events for Jiangsu Yahong Meditech Co., Ltd. Class A